0
Your cart

Your cart is empty

Books > Business & Economics > Industry & industrial studies > Manufacturing industries > Pharmaceutical industries

Buy Now

Considering the Patient in Pediatric Drug Development - How Good Intentions Turned Into Harm (Paperback) Loot Price: R3,217
Discovery Miles 32 170
Considering the Patient in Pediatric Drug Development - How Good Intentions Turned Into Harm (Paperback): Klaus Rose

Considering the Patient in Pediatric Drug Development - How Good Intentions Turned Into Harm (Paperback)

Klaus Rose

 (sign in to rate)
Loot Price R3,217 Discovery Miles 32 170 | Repayment Terms: R301 pm x 12*

Bookmark and Share

Expected to ship within 12 - 19 working days

Considering the Patient in Pediatric Drug Development: How Good Intentions Turned into Harm addresses a fundamental challenge in drug development and healthcare for young patients. In clinical trials and clinical practice, the term "children" is used ambiguously to confer physiological characteristics to a chronological age limit, which in reality does not exist. This book outlines why the United States (US) and European Union's (EU) regulatory authorities, pediatric academia, and the pharmaceutical industry demand, support and perform pediatric drug studies, along with the key flaws of this demand that blurs the different administrative and physiological meanings of the term "child." In addition, the book covers why most pediatric regulatory studies lack medical sense and many even harm young patients and the conflicts of interest behind pediatric drug studies. It includes relevant information about the maturation of the human body regarding absorption, distribution, metabolism and excretion of food and drugs as well as key differences between newborns, infants, older children and adolescents.

General

Imprint: Academic Press Inc
Country of origin: United States
Release date: November 2020
First published: 2021
Authors: Klaus Rose
Dimensions: 229 x 152 x 24mm (L x W x T)
Format: Paperback
Pages: 414
ISBN-13: 978-0-12-823888-2
Categories: Books > Business & Economics > Industry & industrial studies > Manufacturing industries > Pharmaceutical industries
Books > Medicine > General issues > Medical equipment & techniques > Medical research
Books > Medicine > Other branches of medicine > Pharmacology > General
Promotions
LSN: 0-12-823888-7
Barcode: 9780128238882

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

You might also like..

Empire Of Pain - The Secret History of…
Patrick Radden Keefe Paperback R385 R349 Discovery Miles 3 490
Pharmacology In Clinical Practice…
Gustav Schellack Paperback R512 Discovery Miles 5 120
Advanced Nanoformulations - Theranostic…
Md Saquib Hasnain, Amit Kumar Nayak, … Paperback R4,223 Discovery Miles 42 230
Drug Delivery Systems for Metabolic…
Harish Dureja, Narasimha Murthy, … Paperback R4,171 Discovery Miles 41 710
Targeted Nanomedicine for Breast Cancer…
Shivani Rai Paliwal, Rishi Paliwal Paperback R4,773 Discovery Miles 47 730
Tamoxifen Tales - Suggestions for…
V.Craig Jordan Hardcover R2,211 Discovery Miles 22 110
Herbal Bioactive-Based Drug Delivery…
Inderbir Singh Bakshi, Rajni Bala, … Paperback R4,215 Discovery Miles 42 150
Practical Aspects of Vaccine Development
Parag Kolhe, Satoshi Ohtake Paperback R4,223 Discovery Miles 42 230
Process Systems Engineering for…
Ravendra Singh, Zhihong Yuan Hardcover R5,865 R5,428 Discovery Miles 54 280
Evidence-Based Validation of Herbal…
Pulok K. Mukherjee Hardcover R4,549 Discovery Miles 45 490
Orphan Drugs - Understanding the Rare…
Elizabeth Hernberg-Stahl, Miroslav Reljanović Hardcover R4,474 Discovery Miles 44 740
Patently Innovative - How Pharmaceutical…
R A Bouchard Hardcover R4,301 Discovery Miles 43 010

See more

Partners